Literature DB >> 20608776

Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species.

Ahmet Bariş Guzel1, Macit Ilkit, Tuba Akar, Refik Burgut, S Cansun Demir.   

Abstract

Vulvovaginal candidiasis (VVC), particularly the recurrent form, remains an intractable problem for clinicians, microbiologists, and patients. It is essential to confirm the clinical diagnosis by mycological methods and avoid empirical therapy. The recovery of yeast in fungal culture, such as on Sabouraud dextrose agar, remains the gold standard for diagnosis. In this investigation, we examined 474 participants, including 122 (25.7%) with acute VVC cases, 249 (52.5%) who had recurrent VVC (RVVC) cases, and 103 (21.7%) healthy controls. We also administered a questionnaire to obtain information on patient lifestyle and medical, gynecological, and sexual history. In addition, we compared the performance of chromID Candida agar (CAN2) to CHROMagar Candida (CAC) and Sabouraud dextrose agar with gentamicin and chloramphenicol (SGC2). The yeasts were identified by conventional methods including the germ tube test, microscopic morphology on cornmeal-Tween 80 agar, and the commercial API 20C AUX system. We detected yeasts in 60 of 122 (49.2%) patients with acute VVC cases, 110 of 249 (44.2%) with RVVC cases, and in 35 of 103 (34%) healthy controls (P = 0.07). A total of 205 samples were found to be positive for fungi (43.2%), of which 176 (85.9%) were monofungal, and 29 (14.1%) were polyfungal. In addition, 198 of these samples (96.6%) were positive on CAN2, 195 (95.1%) on CAC, 189 (92.2%) on SGC2, and 183 (89.3%) samples on all three (P = 0.17). The 234 yeast isolates recovered were C. albicans (n = 118), C. glabrata (n = 82), C. kefyr (n = 11), C. krusei (n = 9), C. lipolytica (n = 3), C. colliculosa (n = 2), C. parapsilosis (n = 2), C. pelliculosa (n = 2), C. tropicalis (n = 2), and other species of Candida (n = 3). Of the 29 polyfungal populations, 28 (96.6%) were detected in CAN2, 25 in (86.2%) CAC, and 25 (86.2%) on both (P = 0.35). Notably, we detected the high predominance of C. albicans+C. glabrata (86.2%) in polyfungal populations. Briefly, the detection of C. albicans after 24 h of incubation was easier on CAN2 (64.4%) than on CAC (25.4%). This study showed that CAN2 is a rapid and reliable medium for immediate identification of C. albicans and for detecting polyfungal populations in vaginal specimens. We observed that the use of antibiotics, intrauterine devices, as well as, perineal laceration, short anovaginal distance (< 3 cm), and genital epilation in common areas are predisposing factors for RVVC (P < 0.001). In addition, we detected that the use of menstrual pad, using an (IUD), and having a history of childbirth increased the risk of both acute and recurrent VVC (P < 0.01), whereas the use of a daily pad and walking daily significantly decreased the risk of both acute and recurrent VVC (P < 0.01).

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20608776     DOI: 10.3109/13693786.2010.497972

Source DB:  PubMed          Journal:  Med Mycol        ISSN: 1369-3786            Impact factor:   4.076


  15 in total

1.  The Role of PCR in the Diagnosis of Candida Vulvovaginitis-a New Gold Standard?

Authors:  J D Sobel; Robert A Akins
Journal:  Curr Infect Dis Rep       Date:  2015-06       Impact factor: 3.725

2.  An evaluation of risk factors in pregnant women with Candida vaginitis and the diagnostic value of simultaneous vaginal and rectal sampling.

Authors:  Ahmet Barış Guzel; Macit Ilkit; Refik Burgut; Ibrahim Ferhat Urunsak; Fatma Tuncay Ozgunen
Journal:  Mycopathologia       Date:  2011-02-04       Impact factor: 2.574

3.  Lack of Candida africana and Candida dubliniensis in vaginal Candida albicans isolates in Turkey using HWP1 gene polymorphisms.

Authors:  Ramazan Gumral; Banu Sancak; Ahmet Barış Guzel; Mehmet Ali Saraçlı; Macit Ilkit
Journal:  Mycopathologia       Date:  2011-03-06       Impact factor: 2.574

4.  Clinical and Laboratory Features of Six Cases of Candida and Dermatophyte Folliculitis and a Review of Published Studies.

Authors:  Murat Durdu; Mümtaz Güran; Hazal Kandemir; Macit Ilkit; Seyedmojtaba Seyedmousavi
Journal:  Mycopathologia       Date:  2015-09-04       Impact factor: 2.574

5.  Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.

Authors:  Do Ngoc Anh; Dao Nguyen Hung; Tran Viet Tien; Vu Nhat Dinh; Vu Tung Son; Nguyen Viet Luong; Nguyen Thi Van; Nguyen Thi Nhu Quynh; Nguyen Van Tuan; Le Quoc Tuan; Nguyen Duy Bac; Nguyen Khac Luc; Le Tran Anh; Do Minh Trung
Journal:  BMC Infect Dis       Date:  2021-06-03       Impact factor: 3.090

6.  Hosting infection: experimental models to assay Candida virulence.

Authors:  Donna M Maccallum
Journal:  Int J Microbiol       Date:  2011-12-22

7.  Clinical characteristics of Turkish women with Candida krusei vaginitis and antifungal susceptibility of the C. krusei isolates.

Authors:  Ahmet Bariş Güzel; Merve Aydın; Melda Meral; Ayşe Kalkancı; Macit Ilkit
Journal:  Infect Dis Obstet Gynecol       Date:  2013-12-11

8.  Trichomonas, Candida, and gardnerella in cervical smears of Iranian women for cancer screening.

Authors:  Narges Kalantari; Salman Ghaffari; Masomeh Bayani
Journal:  N Am J Med Sci       Date:  2014-01

9.  MTL genotypes, phenotypic switching, and susceptibility profiles of Candida parapsilosis species group compared to Lodderomyces elongisporus.

Authors:  Aylin Döğen; Banu Metin; Macit Ilkit; G Sybren de Hoog; Joseph Heitman
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

10.  Susceptibility and molecular characterization of Candida species from patients with vulvovaginitis.

Authors:  Gheniffer Fornari; Vania Aparecida Vicente; Renata Rodrigues Gomes; Marisol Dominguez Muro; Rosangela Lameira Pinheiro; Carolina Ferrari; Patricia Fernanda Herkert; Marcos Takimura; Newton Sérgio de Carvalho; Flavio Queiroz-Telles
Journal:  Braz J Microbiol       Date:  2016-03-02       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.